Literature DB >> 26743201

Cytomegalovirus Infection in Pediatric Solid Organ Transplant Recipients: a Focus on Prevention.

Karen C Tsai1, Lara A Danziger-Isakov2, David B Banach3.   

Abstract

Solid organ transplantation is a life-saving procedure that has changed the prognosis for infants and children with end-stage organ disease. Cytomegalovirus (CMV) is one of the most common infections that occur after organ transplantation in pediatric patients, yet the standard of care for CMV prevention remains unclear. We review the literature regarding CMV disease effects, risk factors, diagnostics, prevention strategies, and antiviral treatment in pediatric solid organ transplantation. This discussion focuses on the current prevention strategies: prophylaxis, preemptive, and hybrid therapy, as well as novel strategies that may help better prevent the CMV disease in the pediatric solid organ transplant population.

Entities:  

Keywords:  CMV; Cytomegalovirus; Hybrid; Pediatric; Preemptive; Prophylaxis; Solid organ transplantation

Year:  2016        PMID: 26743201     DOI: 10.1007/s11908-015-0511-8

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  79 in total

Review 1.  Cytomegalovirus infection in liver transplant recipients: updates on clinical management.

Authors:  Jasmine Riviere Marcelin; Elena Beam; Raymund R Razonable
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.

Authors:  Deirdre A Kelly; John C Bucuvalas; Estella M Alonso; Saul J Karpen; Upton Allen; Michael Green; Douglas Farmer; Eyal Shemesh; Ruth A McDonald
Journal:  Liver Transpl       Date:  2013-08       Impact factor: 5.799

3.  Cytomegalovirus in solid organ transplantation.

Authors:  R R Razonable; A Humar
Journal:  Am J Transplant       Date:  2013-03       Impact factor: 8.086

4.  Risk factors for chronic rejection after pediatric liver transplantation.

Authors:  P Gupta; J Hart; D Cronin; S Kelly; J M Millis; L Brady
Journal:  Transplantation       Date:  2001-09-27       Impact factor: 4.939

5.  Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis.

Authors:  C V Paya; R H Wiesner; P E Hermans; J J Larson-Keller; D M Ilstrup; R A Krom; S Rettke; T F Smith
Journal:  J Hepatol       Date:  1993-06       Impact factor: 25.083

6.  Generation of HCMV-specific T-cell lines from seropositive solid-organ-transplant recipients for adoptive T-cell therapy.

Authors:  Gordon Brestrich; Sandra Zwinger; Andy Roemhild; Michel Noutsias; Maria Rohde; Kathrin Keeren; Birgit Sawitzki; Hans-Dieter Volk; Petra Reinke; Markus H Hammer
Journal:  J Immunother       Date:  2009 Nov-Dec       Impact factor: 4.456

Review 7.  Management of cytomegalovirus infection and disease in liver transplant recipients.

Authors:  Jackrapong Bruminhent; Raymund R Razonable
Journal:  World J Hepatol       Date:  2014-06-27

8.  CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.

Authors:  Francisco M Marty; Drew J Winston; Scott D Rowley; Estil Vance; Genovefa A Papanicolaou; Kathleen M Mullane; Thomas M Brundage; Alice T Robertson; Susan Godkin; Hervé Momméja-Marin; Michael Boeckh
Journal:  N Engl J Med       Date:  2013-09-26       Impact factor: 91.245

9.  Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study.

Authors:  Susanne Stoelben; Wolfgang Arns; Lutz Renders; Jürgen Hummel; Anja Mühlfeld; Manfred Stangl; Michael Fischereder; Wilfried Gwinner; Barbara Suwelack; Oliver Witzke; Michael Dürr; Dietrich W Beelen; Detlef Michel; Peter Lischka; Holger Zimmermann; Helga Rübsamen-Schaeff; Klemens Budde
Journal:  Transpl Int       Date:  2014-01       Impact factor: 3.782

10.  Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.

Authors:  Giuseppe Gerna; Fausto Baldanti; Maria Torsellini; Lorenzo Minoli; Mario Viganò; Tiberio Oggionnis; Teresa Rampino; Barbara Castiglioni; Antonio Goglio; Michele Colledan; Carmelo Mammana; Francesca Nozza; Lilleri Daniele
Journal:  Antivir Ther       Date:  2007
View more
  1 in total

1.  Impact of standardized protocols for cytomegalovirus disease prevention in pediatric solid organ transplant recipients.

Authors:  Lakshmi Ganapathi; Jennifer Blumenthal; Laila Alawdah; Lynne Lewis; Jennifer Gilarde; Sarah Jones; Carly Milliren; Heung Bae Kim; Tanvi S Sharma
Journal:  Pediatr Transplant       Date:  2019-09-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.